/PRNewswire/ BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products.
StockNews.com upgraded shares of BioLife Solutions (NASDAQ:BLFS – Get Rating) to a sell rating in a research report released on Thursday morning. Other research analysts have also recently issued research reports about the stock. Oppenheimer restated an outperform rating and issued a $28.00 target price on shares of BioLife Solutions in a research report on […]
BioLife Solutions, Inc. (NASDAQ:BLFS – Get Rating) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 2,360,000 shares, an increase of 10.8% from the March 31st total of 2,130,000 shares. Currently, 5.9% of the shares of the stock are sold short. Based on […]
StockNews.com upgraded shares of BioLife Solutions (NASDAQ:BLFS – Get Rating) to a sell rating in a research report sent to investors on Friday morning. Other equities research analysts have also issued research reports about the stock. Oppenheimer reaffirmed an outperform rating and set a $28.00 price target on shares of BioLife Solutions in a research […]
StockNews.com upgraded shares of BioLife Solutions (NASDAQ:BLFS – Get Rating) to a sell rating in a report published on Friday. A number of other research analysts have also commented on the stock. Stephens lowered their price objective on shares of BioLife Solutions from $31.00 to $27.00 and set an overweight rating on the stock in […]